We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
- Authors
Burstein, Harold J; Harris, Lyndsay N; Gelman, Rebecca; Lester, Susan C; Nunes, Raquel A; Kaelin, Carolyn M; Parker, Leroy M; Ellisen, Leif W; Kuter, Irene; Gadd, Michele A; Christian, Roger L; Kennedy, Patricia Rae; Borges, Virginia F; Bunnell, Craig A; Younger, Jerry; Smith, Barbara L; Winer, Eric P
- Abstract
Trastuzumab combined with chemotherapy improves outcomes for women with human epidermal growth factor receptor 2 (HER2) overexpressing advanced breast cancer. We conducted a pilot study of preoperative trastuzumab and paclitaxel, followed by surgery and adjuvant doxorubicin and cyclophosphamide chemotherapy in earlier stage breast cancer.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Vol 21, Issue 1, p46
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2003.03.124